Altrafin AG’s Rocket Lab Corp RKLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-70,316
Closed -$265K 73
2022
Q4
$265K Sell
70,316
-586
-0.8% -$2.56K 0.16% 65
2022
Q3
$289K Sell
70,902
-2,425
-3% -$12K 0.17% 69
2022
Q2
$278K Sell
73,327
-148
-0.2% -$871 0.15% 71
2022
Q1
$591K Buy
73,475
+857
+1% +$7.97K 0.23% 69
2021
Q4
$892K Buy
+72,618
New +$998K 0.32% 63

Other funds holding RKLB

Altrafin AG's RKLB Position: Q1 2023 in Review

Altrafin AG sold out of Rocket Lab Corp (RKLB) in Q1 2023, closing a stake of 70,316 shares — an estimated $265K sold.

Altrafin AG first reported a position in RKLB in Q4 2021 and held it in 5 quarters. The position peaked at $892K in Q4 2021. 191 funds tracked by Wall St. Rank hold RKLB as of Q1 2023.

  • Altrafin AG reported no remaining Rocket Lab Corp position as of Q1 2023 after selling out during the quarter.
  • Altrafin AG sold 70,316 Rocket Lab Corp shares in Q1 2023, an estimated $265K.
  • Altrafin AG first reported a position in Rocket Lab Corp in Q4 2021 and held it in 5 quarters.
  • Altrafin AG's Rocket Lab Corp position peaked at $892K in Q4 2021.
  • 191 funds tracked by Wall St. Rank held Rocket Lab Corp as of Q1 2023.

Based on Altrafin AG's 13F filing for Q1 2023, filed 17 Feb 2026.